New York Legislator Introduces Bill to Legalize Psilocybin Treatment
“Establishing a widespread route to provide New Yorkers with this medical treatment would be a monumental step in providing mental health care to improve lives,” reads the bill.
psilocybin
Compass Pathways Study Finds SSRI Drugs Did Not Impede Psilocybin’s Therapeutic Effect
Chief Medical Officer Guy Goodwin calls study “a strong signal that COMP360 psilocybin therapy could be an adjunctive treatment to SSRI antidepressant as well as a monotherapy.”
Microdosing LSD and Psilocybin Rises During Pandemic, Global Drug Survey Finds
The report also explores how microdosing may impact the use of other prescribed mental health medications.
Psychedelic Business Spotlight: December 3
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress; Compass Pathways gets new majority stakeholder.
DEA Boosts Psychedelics Production (Again) to Meet Research Demand
Drug Enforcement Agency also addresses concerns from Native American Church regarding peyote poaching for mescaline research.
Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy Trial
Chief Medical Officer Dr. Guy Goodwin clarifies “COMP360 psilocybin therapy was generally well-tolerated” by patients with treatment-resistant depression, despite some adverse reactions from subjects in the study.
Can Psychedelics Cure Chronic Pain? This Promising Study Lays Groundwork for Future Clinical Trials
Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating with psychedelics.
New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression
“If the results are confirmed in subsequent studies … antidepressants may no longer need to be stopped for psilocybin treatment,” says MindMed Executive President Dr. Miri Halperin Wernli.
Combining Psychedelics: Is It Safe?
Mixing psychedelics goes by many names in pop culture: hippie flipping (MDMA and mushrooms) and candy flipping (MDMA and LSD), to name two. Depending on how you go about it, the experience can be life-affirmingly euphoric or severely overwhelming. But is it ever worth the risk?
How the COVID Pandemic Inspired Wakeful Travel’s Psychedelic Integration Journals
A travel journal company pivots from external trips to those unfolding in the mind, and the psychedelic community is embracing the one-of-a-kind integration workbook with open arms.
End of content
End of content